Cleocin and Azelastine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cleocin (clindamycin phosphate) and Azelastine (azelastine hydrochloride). Common drug interactions include drug hypersensitivity among females and sinusitis among males.

The phase IV clinical study analyzes what interactions people have when they take Cleocin and Azelastine. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Cleocin?

Cleocin has active ingredients of clindamycin phosphate. It is often used in infection. eHealthMe is studying from 3,940 Cleocin users. Check the latest studies of Cleocin.

What is Azelastine?

Azelastine has active ingredients of azelastine hydrochloride. It is often used in allergies. eHealthMe is studying from 17,400 Azelastine users. Check the latest studies of Azelastine.

On Jul, 28, 2026

20 people who take Cleocin and Azelastine together, and have interactions are studied.

Cleocin and Azelastine drug interactions.

What are the common drug interactions of Cleocin and Azelastine, by gender? *:

female:

Drug hypersensitivity
Abscess (pus)
Cellulitis (infection under the skin)
Fibromyalgia (a long-term condition which causes pain all over the body)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Nephrolithiasis (calculi in the kidneys)
Sepsis (a severe blood infection that can lead to organ failure and death)
Septic shock (shock due to blood infection)
Abdominal discomfort
Abdominal distension

male:

Sinusitis (inflammation of sinus)
Chronic kidney disease
Sepsis (a severe blood infection that can lead to organ failure and death)
Skin ulcer
Drug ineffective
Labyrinthitis (inflammation of the labyrinth or inner ear)
Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
Pain
Pyrexia (fever)
Rash

What are the common drug interactions of Cleocin and Azelastine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
Rash
Scrotal abscess (pus in scrotum)
Sepsis (a severe blood infection that can lead to organ failure and death)
Skin ulcer

50-59:

n/a

60+:

Abscess (pus)
Cellulitis (infection under the skin)
Genital infection
Pain
Pelvic fracture
Pyrexia (fever)
Renal failure (kidney dysfunction)
Wrist fracture
Sepsis (a severe blood infection that can lead to organ failure and death)
Septic shock (shock due to blood infection)

What are the existing conditions these people have? *

Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 25.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 25.00%
Type 2 Diabetes: 4 people, 20.00%
Weight Decreased: 3 people, 15.00%
Pain: 3 people, 15.00%
Hypotension (abnormally low blood pressure): 3 people, 15.00%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 3 people, 15.00%
Diabetes: 2 people, 10.00%
High Blood Pressure: 2 people, 10.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cleocin and Azelastine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously